FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025

Feb 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-01-31

Reporting Person: Andrade Robert (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-31	Common shares	A	1042	—	Acquired	130507	Direct

Footnotes

F1: Represents shares released from restriction from shares awarded 3-31-2023.